Dusa Pharmaceuticals, Inc. (DUSA) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	426.34K
Accretion of premiums and discounts on marketable securities	-51
Share-based compensation	1.85M
Depreciation and amortization	442.69K
Loss on change in fair value of warrants	2.31M
Gain on sale of assets
Deferred revenues recognized	-7.54K
Accounts receivable	957.27K
Inventory	-956.26K
Prepaid and other assets	472.14K
Accounts payable, accrued compensation and other accrued expenses	-85.24K
Other liabilities	-19.77K
NET CASH PROVIDED BY OPERATING ACTIVITIES	4.74M
Purchases of marketable securities	-2M
Proceeds from maturities and sales of marketable securities	2.2M
Proceeds from sale of assets
Restricted cash	-335
Purchases of property, plant and equipment	-496.38K
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	-295.43K
Stock option exercises	375.8K
Settlements of restricted stock for tax withholding obligations	-508.57K
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	-132.77K
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	4.31M
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	24.42M
CASH AND CASH EQUIVALENTS AT END OF PERIOD	28.74M

Entities mentioned with DUSA

View All Entities